Virax Biolabs Group Limited - Ordinary Shares (VRAX)
1.6100  0.00 (0.00%)

Virax Biolabs Group Limited is a biotechnology company focused on developing and commercializing innovative diagnostic solutions and therapeutics for viral infections, particularly in the fields of healthcare and disease prevention. The company leverages advanced technologies to create accurate diagnostic kits that aim to identify various viral pathogens, thereby aiding in effective disease management and treatment strategies. Virax is committed to enhancing global health outcomes by providing accessible and reliable testing solutions, which play a critical role in the early detection and monitoring of viral diseases.

SummaryNewsPress ReleasesChartHistorical
Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
Investors in healthcare and biotech sectors should keep an eye on several prominent companies making strides in innovation, clinical trials, and global expansion. Modular Medical (NASDAQ: MODD), Cardiol Therapeutics (NASDAQ: CRDL) , DBV Technologies (NASDAQ: DBVT) , and Virax Biolabs (NASDAQ: VRAX) are key players to watch in the ever-evolving medical landscape. Each company has announced significant developments in technology, trials, and product distribution, solidifying their positions in the market.
Via AB Newswire · October 23, 2024
Virax Biolabs (NASDAQ: VRAX) Launches Triple Virus Antigen Test Kit For RSV, Flu and COVID
Virax Biolabs, Inc. (NASDAQ: VRAX) is engaged as a biotechnology company, which is focused on the prevention, detection and diagnosis
Via Spotlight Growth · November 3, 2022
Monkeypox vaccine and research related stocks taking center stage (VRAX,GOVX,TNXP,APDN)
WH recently announced that its expanding monkeypox vaccination efforts. The infection seems to be slowed down in some major cities like New York and Chicago. However, cases seem to be popping in other parts of the country. Greenwood District 50 Schools revised its statement released Wednesday night to classify the incident as a "potential case of moneypox," after a request from the South Carolina Department of Health and Environmental Control. DHEC has not identified the individual. On July 29 New York State governor, Kathy Hochul, declared the monkeypox outbreak a state emergency. On August 2, president Joe Biden named two federal officials, Bob Fenton and Dr. Daskalakis to lead and accelerate the U.S. government's response against monkeypox.
Via AB Newswire · September 2, 2022
Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit
Kits Available in July for Distribution
By Virax Biolabs Group Limited · Via GlobeNewswire · July 26, 2022